http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105418480-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105418480-B |
| titleOfInvention | The preparation and application of 2- (1- (4- chlorobenzene formacyl) -5- methoxyl group -2- methyl-1 hydrogen-indol-3-yl)-N- hydroxyl acetamide |
| abstract | The invention belongs to field of pharmaceutical chemistry technology more particularly to histon deacetylase (HDAC) inhibitor and its preparation method and application.The present invention provides a kind of potent histon deacetylase (HDAC) inhibitors to further relate to its pharmaceutically acceptable salt, solvate and prodrug the present invention relates to the compound with structure formula (I).The invention further relates to pharmaceutical compositions and its pharmaceutical applications containing structure formula (I) compound.The disease of histone deacetylase activity unconventionality expression can effectively be treated.The structural formula of formula (I) compound are as follows: |
| priorityDate | 2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.